CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED)
Research and development	$ 4,628,535	$ 6,083,488	$ 8,981,044	$ 11,476,034
General and administrative	2,447,413	2,092,758	4,580,791	4,350,761
Total operating expenses	7,075,948	8,176,246	13,561,835	15,826,795
Operating loss	(7,075,948)	(8,176,246)	(13,561,835)	(15,826,795)
Interest expense, net	(182,701)	(159,063)	(380,397)	(311,852)
Other expense	(13,758)	(7,500)	(12,183)	(57,671)
Net loss	(7,244,891)	(8,342,809)	(13,954,415)	(16,196,318)
Modification of warrants			0	(171,552)
Net loss available to common shareholders	$ (7,244,891)	$ (8,342,809)	$ (13,954,415)	$ (16,367,870)
Net loss per common share - basic and diluted	$ (0.14)	$ (0.19)	$ (0.28)	$ (0.38)
Weighted average common shares outstanding - basic and diluted	52,006,442	43,588,381	50,228,860	43,513,571